Stock Price
23.76
Daily Change
1.18 5.23%
Monthly
-14.41%
Yearly
5.74%
Q1 Forecast
23.84

Celldex Therapeutics reported $730K in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Amgen USD 6.48B 307M Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Celldex Therapeutics USD 730K 35K Jun/2025
Glaxosmithkline GBP 8.75B 2.92B Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Roche Holding CHF 22.09B 10.04B Dec/2025